February 20, 2025
bioMérieux acquires Neoprospecta, a Brazil-based company dedicated to data and genomics solutions for microbial risk management in food and pharma industries
bioMérieux, a world leader in the field of in vitro diagnostics, has finalized the closing of the acquisition of Neoprospecta on January 29th, 2025. A Sale and Purchase Agreement (SPA) to acquire this Brasilian-based company was signed in November 2024. Neoprospecta, based in Florianopolis, develops and markets innovative user-friendly data and genomics solutions for augmenting quality assurance programs and improve microbiological risk prevention in food and pharma industries.
